Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Timothy Wilkin, MD, MPH
Weill Medical College of Cornell University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alabama Crs (site Id# 31788)
Birmingham, Alabama, United States
- Ucla Care Center Crs
Los Angeles, California, United States
- Ucsd Antiviral Research Center Crs (site Id: 701)
San Diego, California, United States
- University of California, San Fransisco Hiv/aids Crs
San Francisco, California, United States
- Whitman-Walker Institute, Inc. Crs (site Id: 31791)
Washington D.C., District of Columbia, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Massachusetts General Hospital Crs (mgh Crs) (site Id: 101)
Boston, Massachusetts, United States
- Washington University Therapeutics (wt) Crs
St Louis, Missouri, United States
- New Jersey Medical School Clinical Research Center Crs [site Id: 31786]
Newark, New Jersey, United States
- Columbia P&s Crs
New York, New York, United States
- Weill Cornell Uptown Crs (site Id: 7803)
New York, New York, United States
- Chapel Hill Crs (site Id: 3201)
Chapel Hill, North Carolina, United States
- Case Clinical Research Site
Cleveland, Ohio, United States
- Penn Therapeutics, Crs (site Id: 6201)
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 May 2021
- Primary completion
- 30 Jun 2026
- Completion
- 30 Dec 2026
- Last update posted
- 25 Mar 2025
- Registered enrollment
- 118
- Registry id
- NCT04340596
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.